Cabozantinib for the Treatment of Advanced Hepatocellular Carcinoma: Current Data and Future Perspectives-Reference-Cited by-同舟云学术

Cabozantinib for the Treatment of Advanced Hepatocellular Carcinoma: Current Data and Future Perspectives

Published:2020-07-15 Issue:12 Volume:80 Page:1203-1210
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Trojan Jörg^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40265-020-01361-5.pdf

Reference43 articles.

1. World Health Organization, News room, fact sheets, cancer. In: WHO [Internet]. 12 Sep 2018. http://www.who.int/news-room/fact-sheets/detail/cancer.

2. European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236.

3. Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359(4):378–90.

4. Cheng AL, Kang YK, Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2009;10:25–34.

5. Bruix J, Qin S, Merle P, et al. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;389(10064):56–66.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small-molecule-based targeted therapy in liver cancer;Molecular Therapy;2024-08

2. Ti3C2 (MXene), an advanced carrier system: role in photothermal, photoacoustic, enhanced drugs delivery and biological activity in cancer therapy;Drug Delivery and Translational Research;2024-05-07

3. Tumor-Extrinsic Axl Expression Shapes an Inflammatory Microenvironment Independent of Tumor Cell Promoting Axl Signaling in Hepatocellular Carcinoma;International Journal of Molecular Sciences;2024-04-10

4. From MASH to HCC: the role of Gas6/TAM receptors;Frontiers in Immunology;2024-01-17

5. Linoleate-pazopanib conjugation as active pharmacological ingredient to abolish hepatocellular carcinoma growth;Frontiers in Pharmacology;2024-01-16